The Bird Flu Virus Is Mutating Fast – And Scientists Say Our Vaccines May Not Be Enough
H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...
Fusing two immune system proteins leads to a new method of generating antibodies
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...
Hosted on MSN9d
H5N1 influenza viral lineages beginning to evade human immunological defenses, research finds
Discovery of "an overall worsening in antibody affinity to more recent H5N1 isolates" indicates current and future H5N1 viral ...
Humans May Be Able to Grow New Teeth Within Just 5 Years
Now, Japanese researchers are moving a promising, tooth-regrowing medicine into human trials. If the trial is successful, the ...
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
If bird flu jumps to humans, immunity from seasonal flu may offer some protection
Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems ...
GEN - Genetic Engineering and Biotechnology News11d
Antibodies Against H5N1 More Likely in Adults with History of Flu Infections
Previous exposures to older flu strains prime the immune system to produce antibodies against bird flu (H5N1).
Pharmabiz4d
Harbour BioMed inks collaboration with AstraZeneca to discover and develop next-generation therapeutic antibodies
Harbour BioMed inks collaboration with AstraZeneca to discover and develop next-generation therapeutic antibodies: Shanghai & Rotterdam, The Netherlands Tuesday, March 25, 2025, 1 ...
BioSpace5d
Gene Editing, Next-Gen Antibodies Key to Unlocking Animal-to-Human Transplants
It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...
SAB Biotherapeutics (SABS) to Release Earnings on Thursday
SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) is expected to issue its quarterly earnings data before the market opens ...
EurekAlert!11d
H5N1 influenza viral lineages beginning to evade human immunological defenses, UNC Charlotte research finds
New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...